Posted by AGORACOM
at 11:47 AM on Thursday, November 14th, 2019
23 holes drilled in the last two years have intersected significant mineralization and dramatically increased the size of the Goldstorm deposit at Treaty Creek
Eric Sprott re-emphasized the potential of the project in a podcast where he stated that he is “hoping they can prove up a 20-million-ounce depositâ€
11:30 –“I still believe there’s going to be huge deposit proven
up there. If we get the right environment in precious metals, which it
looks like we might be getting here, people are going to start looking
at these things again, and it could be very, very exciting, so…and I am,
kind of, hoping that they can ultimately pull up, like, a 20 million
ounce deposit there. So these stocks would prove to be very, very
inexpensiveâ€
SUMMARIZING THE 2019 PROGRAM
The Company’s JV partner, Tudor Gold’s 2019 exploration program at
the Goldstorm Zone on Treaty Creek totalled 9,781.8 meters with 14
diamond drill holes. This year’s drilling program generated the best
near-surface results attained to date on the project. Specifically, in
addition to several hundred meters extension along strike to the
northeast, the 2019 program significantly expanded the mineralized
limits to the southeast, where one of the best near-surface intervals
averaged 2 g/t Au over 87m, within 336 m averaging 1 g/t Au in hole GS19-52.
RESULTS OF THE FINAL 5 DRILL HOLES
Hole GS19-49 was drilled to 960.1 m, at -80° dip, on Section
111+00 NE next to the previously announced vertical hole GS19-48, which
yielded 0.725 g/t Auover 838.5m, including an upper horizon that averaged 1.048 g/t gold Au over 328.5 m. Hole GS19-49 returned equally impressive results with a comparable 0.7 g/t Au over 826.5 m and the upper horizon averaging 1 g/t Au over 249 m
Along
the same section, hole GS19-52 (-50° dip at 115° azimuth) was drilled
much longer than expected because the Goldstorm System continues at
least 700 m to the southeast ; GS19-52 averaged 1 g/t gold over 336 meters with a higher grade core of 2 g/t gold over 87 meters within the upper horizon.
Tudor Gold Exploration Manager, Ken Konkin explained:
“Clearly the results of the previously reported deep vertical step-out
holes demonstrate the impressive size and grade consistency of the
Goldstorm system. Within the overall mineralized package of fragmental
intermediate volcanic rocks there are several sub-horizontal horizons of
significantly higher gold grades. The uppermost portions of the
previously reported holes GS19-42, GS19-47 and GS19-48 contained
respectively, 1.268 g/t gold over 252 m, 0.828 g/t gold over 301.5 m and
1.048 g/t gold over 328.5 m. We now have several other drill holes with excellent near-surface gold values to add to this list of growing intercepts. GS19-52 has returned the highest core gold grades of 2.006 g/t Au over 87 m within a 336m intercept of 1.004 g/t Au.
These
intercepts are part of the uppermost portion of the Goldstorm system
which we refer to as the ‘300 Horizon’. The ‘300 Horizon’ remains open
along strike to the northeast as well as to the southeast. In addition,
the lower horizons of the Goldstorm system also remain open in all
directions and the lowest horizon is open at depth.â€
Furthermore, Mr. Konkin added:
“We are seeing consistent silver and copper mineralization associated
with the deeper gold horizons such as the previously reported 151.5 m zone of 0.572 g/t gold, 8.5 g/t silver and 0.21% copper that was intercepted from 665.0 to 816.5 m in GS19-47 and a 66.0 m zone with 0.958 g/t gold, 3.9 g/t silver and 0.35% copper, whichwas intercepted from 874.5 to 940.5 m in GS19-48. Similarly, we have now seen in GS19-49, a 78 m intercept averaging 1.145 g/t gold, 11.2 g/t silver and 0.21% copper (750-828 m) and in GS19-52 an 88.5 m interval averaging 0.352 g/t gold, 9.3 g/t silver and 0.25% copper (515-603.5
m). Not only does the Goldstorm Zone remain open at depth and along
strike, we are now seeing base-metal associations possibly as part of a
zonation within the hydrothermal system.â€
The final three footwall
extension holes (GS19-50, GS19-51 and GS19-53) were completed on
section 110+00 NE. These were successful in extending the width of the
mineralized zone to the southeast:
Hole GS19-50 returned an average of 0.602 g/t Au over 577.5 m including 0.811 g/t Au over 267.0 m in the ‘300 Horizon‘
Hole GS19-51 returned an average of 0.721 g/t Au over 246 m in the ‘300 Horizon’ and a lower horizon that averages 1.017 g/t Au over 40.5 m.
Hole GS19-53 returned an average of 0.984 g/t Au over 147.0 min the ‘300 Horizon’
About American Creek
American
Creek is a Canadian junior mineral exploration company with a strong
portfolio of gold and silver properties in British Columbia.
Three
of those properties are located in the prolific “Golden Triangleâ€; the
Treaty Creek and Electrum joint venture projects with Tudor Gold/Walter
Storm as well as the 100% owned past producing Dunwell Mine.
The
Treaty Creek Project is a Joint Venture with Tudor Gold owning 60% and
acting as operator. American Creek and Teuton Resources each have 20%
interests in the project. American Creek and Teuton are both fully
carried until such time as a Production Notice is issued, at which time
they are required to contribute their respective 20% share of
development costs. Until such time, Tudor is required to fund all
exploration and development costs while both American Creek and Teuton
have “free ridesâ€.
The
Corporation also holds the Gold Hill, Austruck-Bonanza, Ample Goldmax,
Silver Side, and Glitter King properties located in other prospective
areas of the province.
For further information please contact Kelvin Burton at: Phone: 403 752-4040 or Email: [email protected]. Information relating to the Corporation is available on its website at www.americancreek.com.
Hub on Agoracom FULL DISCLOSURE: American Creek is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM
at 8:26 AM on Thursday, November 14th, 2019
Thunder Bay, Ontario–(Newsfile Corp. – November 14, 2019) – ZEN Graphene Solutions Ltd. (TSXV:ZEN) (“ZEN” or the “Company“) has signed the definitive graphene manufacturing process License Agreement referred to in a news release on May 30, 2019. This
agreement licenses to ZEN the intellectual property created by
scientists and laboratories within a renowned Canadian University. This
agreement has no expiry date and provides that a royalty is payable by
ZEN based on the annual amount of material processed under the
intellectual property.
The
company also reports that it has signed an 18-month exclusive initial
option agreement with the University of Guelph (Guelph) for intellectual
property regarding an electrochemical exfoliation (ECE) process to
produce Graphene Oxide. In addition, the University of British Columbia
(UBC) and ZEN have begun negotiating a Collaborative Research Agreement
(CRA) template that will form the basis of each agreement with various
UBC researchers. Neither Guelph nor UBC is party to the definitive
agreement mentioned above.
The
definitive License Agreement took effect November 1, 2019 and
subsequently ZEN has begun investing in certain equipment required under
this process. ZEN anticipates that the equipment will be installed
during Q1 2020 at its Guelph location thereby allowing the Company to
start production of this graphene product for market development and
subsequent sale.
The
exclusive agreement with Guelph results from research and development
by Prof. Aicheng Chen and his group. Early results from this process are
very encouraging with Albany Graphite significantly outperforming both
flake/sedimentary graphite and synthetic graphite, demonstrating again
the uniqueness of ZEN’s graphite and its superior performance to
exfoliate into graphene products.
Several
researchers at UBC Okanagan continue to work with ZEN’s material in
multiple areas including the synthesis of Graphene Quantum Dots and
Graphene Oxide, along with multiple applications including battery
anodes, polymers, aluminum, concrete, coatings, and others. Given that
collaboration amongst UBC researchers is expected, this intellectual
property template should accelerate the science by eliminating
repetitive negotiation with each research team at UBC. ZEN will report
on material final agreements with UBC as they are executed.
About ZEN Graphene Solutions Ltd.
ZEN
is an emerging graphene technology solutions company with a focus on
the development of graphene-based nanomaterial products and
applications. The unique Albany Graphite Project provides the company
with a competitive advantage in the potential graphene market as
independent labs in Japan, UK, Israel, USA and Canada have independently
demonstrated that ZEN’s Albany Graphite/Naturally PureTM is an ideal
precursor material which easily converts (exfoliates) to graphene, using
a variety of mechanical, chemical and electrochemical methods.
Posted by AGORACOM-JC
at 8:23 AM on Thursday, November 14th, 2019
5,807 patient visits generated revenue of $663,003, compared to 1,864 patient visits that generated $279,850 for Q3 2018.
Cash used in operating activities improved by $1,309,913 from $3,129,583 for YTD 2018, compared to $1,819,670 for YTD 2019.
VANCOUVER, Nov. 14, 2019 - EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (OTC: EPWCF) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., has filed today its unaudited condensed interim consolidated financial statements for the three and nine months ended September 30th, 2019 and related management’s discussion and analysis, both of which are available at www.SEDAR.com. All financial information in this press release is reported in United States dollars, unless otherwise indicated.
“Our focus on operational excellence and cost controls are key
contributors to strong year-over-year growth numbers and the reduction
in direct clinic expense, as we continue to serve the 165,000 patients
in our database,” said Steven McAuley, Empowers Chairman
& CEO. “The Company is beginning to fulfill its promise of vertical
integration with the build-out of the extraction and production center
in Portland, OR plus with an increased focus on our
proprietary CBD product lines and diversified clinic revenues, the
Company has a clear path of growth and profitability going forward.”
Q3 2019 Highlights
5,807 patient visits generated revenue of $663,003, compared to 1,864 patient visits that generated $279,850 for Q3 2018.
Net loss of $504,531, compared to $378,657
for Q3 2018, which was primarily driven by increased revenues and fair
value adjustments offset by net increased in operating expenses related
to the operations of Sun Valley.
Cash used in operating activities improved by $1,309,913 from $3,129,583 for YTD 2018, compared to $1,819,670 for YTD 2019.
Cash at September 30, 2019 of $178,578, compared to $157,668 at December 31, 2018, which was primarily driven by debt and equity financings during the nine months ended September 30, 2019
and partially offset by cash used in operations, the cash investment in
Sun Valley and cash investment in Sun Valley Health Franchise launch.
Highlights
Strategic redirection: The Company has been
re-positioning its overall strategy to become a vertically integrated
health and wellness brand that connects to its 165,000 patients using a
data driven focus to improve patients’ lives with products, technology
and health systems.
Experienced and Seasoned Board of Directors: The Company Board of Directors includes its CEO Steven McAuley, Dustin Klein,
the Co-Founder of Sun Valley Clinics and the SVP, Business Development
and Andrejs Bunkse, owner and practicing attorney of Rain Legal and
Counsel to numerous cannabis enterprises in the U.S. and Canada.
Strategic Development: The Company has opened its first hemp-derived CBD extraction facility in greater Portland, Oregon
with the first extraction system expected to have the capacity to
produce 6,000 kg of extracted product per year. The Company took
possession of the new extraction facility June 1st, 2019
and has been awarded it’s hemp-handlers licence from the Oregon
Department of Agriculture, allowing the Company to enter the next phase
of build-out and full operations in 2019. The Company expects
preliminary production of its Sollievo CBD line to take place in the
extraction center in 4Q 2019.
Strategic Partnership: The Company has entered into a
Letter of Intent (“LOI”) to form a Joint Venture Partnership (“JV”) with
Heritage Cannabis Holdings Corp (CSE: CANN) (“Heritage”). Terms of the
LOI have Empower and Heritage each with a 50% ownership of the JV.
Heritage will install extraction units and related downstream extraction
equipment inside Empower’s existing licenced hemp processing facility
in Sandy, Oregon. Once operational, the JV will begin
producing proprietary branded products for Empower’s clinics and third
party partners for distribution in the United States.
2019 Outlook and Catalysts
Enhanced Corporate Governance: The Company has prioritized corporate governance practices under the leadership of its Board of Directors and Chairman Steven McAuley, to ensure financial and accounting controls operate at the highest of standards.
Improved Capital Markets Profile: Empower is
diversifying its business model to become a vertically integrated
operator in the global cannabis sector with a focus on patient care, CBD
product distribution, research & development and CBD product
extraction. The Company believes this will appeal to a broader base of
shareholders and investors and provide greater access to capital and
improved trading liquidity.
Increased Patient Access: With a rapidly expanding
company-owned clinic network and significant expansion opportunity
through the Sun Valley Health franchise model, Empower anticipates it
will grow its total patient list substantially in the years ahead. This
is expected to provide greater opportunity for treatment analysis using
artificial intelligence (AI), through progressive initiatives that
include adding the Endocanna DNA test kit to the Company product &
service offering in clinics and online. Ensuring the Company is a leader
in understanding the efficacy of cannabis-related treatment options is
an imperative.
Focus on CBD Product Sales: The Company has launched
its online store to sell its lines of hemp-derived CBD based products
and premium health & wellness supplements. Customers can purchase
products, including CBD lotions, tinctures, spectrum oils, capsules,
lozenges, patches, e-drinks, topical lotions, gel caps, hemp extract
drops and pet-elixir hemp extract drops. Patients and customers will be
able to access Sun Valley Health customer service, home delivery and
e-commerce platforms.
Market Leading Technology: Empower utilizes
market-leading patient electronic management and POS system that is
HIPAA compliant and provides deep insight to patient care. The Company
supports remote patients using its tele-medicine portal, enabling
patients who do not live near one of its clinic locations, or are
disabled or unable to come to a location, to still benefit from a doctor
consultation.
New Modalities and Services: The Company has launched
new physician based modalities and services into the Sun Valley Health
clinics and has commenced booking appointments and providing the new
services. Each of these services provides the opportunity for increased
patient retention, higher revenue per patient visit and increased
patient visits per year. The new services include:
Physician’s CBD Enhanced Massage, Acupuncture, or Cupping Sessions
Neurotransmitter (urine) Profile & Physician Consultation/Action Plan
Spectracell Micronutrient Test & Physician Consultation/Action Plan
Launches Nationwide Franchise: The Company has launched
its nationwide franchise program under the Sun Valley Health brand to
dramatically grow our clinic & store footprint increasing direct
access to patients and to sell hemp-derived CBD products and premium
wellness products directly to our customers and online at our new
e-commerce store at www.sunvalleyhealth.com
Financial Summary
$, except patient visits
Three months ended
September 30,
Nine months ended
September 30,
2019
2018
2019
2018
Patient visits
5,807
1,864
11,304
6,293
Clinic revenues
663,003
279,850
1,406,872
894,477
Direct clinic expenses
(55,397)
(88,956)
(177,560)
(301,392)
Loss from operations
(843,897)
(405,048)
(2,547,276)
(3,716,474)
Net loss
(504,531)
(378,657)
(2,359,579)
(5,132,848)
Net loss per share
(0.00)
(0.01)
(0.02)
(0.09)
Financial Performance
Clinic revenues for Q3 2019 were $663,003, compared to Q3 2018 revenues of $279,850. This increase over the prior year is attributable to the acquisition of Sun Valley Clinics.
Direct clinic expenses for Q3 2019 were $55,397, compared to Q3 2018 direct clinic expenses of $88,956.
These expenses declined despite the increase in revenues due to
improved operational controls to align labor cost with direct patient
consultations. The Company employs a diverse mix of physicians and
practitioners.
Net loss from operations for Q3 2019 was $843,897, compared to Q3 2018 net loss of $405,048.
This increase in loss over prior year is primarily attributable
operating expenses increasing due to timing of recognition of the
expense associated with non-cash share-based awards to management.
Net loss for Q3 2019 was $504,531, respectively, compared to Q3 2018 net loss of $378,657.
This increase over prior year is primarily attributable to the increase
in operating expenses as noted above, which was partially offset by
gains on change in fair value of the conversion option of convertible
debentures and warrants.
During Q3 2019, the Company used $1,819,670 in cash from operations after changes in non-cash working capital. The Company invested $629,636 for the acquisition of Sun Valley Clinics and raised $2,470,216 via proceeds from various issuances of shares, convertible debentures and notes.
Please refer to the Company’s unaudited condensed interim
consolidated financial statements, related notes and accompanying
management discussion and analysis for a full review of the operations.
ABOUT EMPOWER
Empower is a vertically integrated and growth-oriented CBD life
sciences company, and a multi-state operator of medical health &
wellness clinics, operating the Sun Valley Health clinic brand www.sunvalleyhealth.com, for its nine corporate locations and for franchises in the United States.
As a CBD product manufacturer under the Sollievo brand, the Company
distributes its lines through clinics, online and through retail
partners. Extraction operations are currently being developed in the
Company’s new extraction facility in Oregon.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley Chief Executive Officer
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws. All
statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release. Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding; the Company’s intention to open a hemp-based CBD
extraction facility, the expected benefits to the Company and its
shareholders as a result of the proposed acquisitions and partnerships;
the terms of the proposed acquisitions and partnerships; the
effectiveness of the extraction technology; the expected benefits for
Empower’s patient base and customers; the benefits of CBD based
products; the effect of the approval of the Farm Bill; the growth of the
Company’s patient list and that the Company will be positioned to be a
market-leading service provider for complex patient requirements in 2019
and beyond. Such statements are only projections, are based on
assumptions known to management at this time, and are subject to risks
and uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
forward-looking statements, including; that the Company may not open a
hemp-based CBD extraction facility; that the hemp-based CBD extraction
facility may not be fully operational in 2019 if at all; that
legislative changes may have an adverse effect on the Company’s business
and product development; that the Company may not be able to obtain
adequate financing to pursue its business plan; general business,
economic, competitive, political and social uncertainties; failure to
obtain any necessary approvals in connection with the proposed
acquisitions and partnerships; and other factors beyond the Company’s
control. No assurance can be given that any of the events anticipated by
the forward-looking statements will occur or, if they do occur, what
benefits the Company will obtain from them. Readers are cautioned not to
place undue reliance on the forward-looking statements in this release,
which are qualified in their entirety by these cautionary statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements in this release, whether as a result of new information,
future events or otherwise, except as expressly required by applicable
laws.
Posted by AGORACOM-JC
at 4:30 PM on Wednesday, November 13th, 2019
Why Empower Clinics?
A leading owner/operator of physician staffed health and pain management clinics.
Patient database of over 165,000 patients
Platform generating $4MM USD in revenue annually (2019)
Q3 2019 preliminary unaudited revenue saw a year over year growth of approximately 138%
Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
Launching CBD extraction facility
First extraction system capacity = 6,000 Kg per year.
CBD based products are poised to be a $20B global industry by 2022
Medical cannabis is poised to be a $100B global industry by 2025
The Team
The Products
Commenced selling its proprietary line of CBD-based products called SOLLIEVO
Empower’s patient base and customers are
expected to benefit from access to high margin derivative products,
including CBD lotion, tinctures, spectrum oils, capsules, lozenges,
patches, e-drinks, topical lotions, gel caps, hemp extract drops and pet
elixir hemp extract drops.
Patients and customers will be able to access Empower’s home delivery and e-commerce platform.
CBD Extraction
Opening first CBD Extraction facility in Portland, OR.
5,000 sq. ft. leased building with first extraction system capable
of producing 20kg per day of 99% spectrum oil, isolate or distillate
Current wholesale pricing is $6,500 USD per kg with annual capacity of 6,000kg an estimated $39MM USD revenue.
Facility can scale to four extraction systems for up to 24,000kg of product and over $150MM USD revenue
FULL DISCLOSURE: Empower Clinics is an advertising client of AGORA Internet Relations Corp.
Tags: Cannabis, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in All Recent Posts, Empower Clinics Inc. | Comments Off on CLIENT FEATURE: Empower Clinics With 165,000 Patients Already, $CBDT.ca Is Positioned To Become A Medical #Cannabis & #CBD Retail Killer $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca
Posted by AGORACOM-JC
at 3:21 PM on Wednesday, November 13th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Digital Health Market Value to Reach USD 511 Billion by 2026
Demand for digital health is rising on account of the increasing need to improving workflow efficiency across hospitals and other healthcare organizations
In addition to this, there is mounting pressure from governments to reduce healthcare costs, while at the same time focus on improving quality of patient care
The global digital health market value is expected to reach around USD 511 billion by 2026.
The global digital health market is expected to rise exponentially in
the coming years. The already multi-billion industry is likely to grow
at an accelerated pace, as healthcare sector welcomes digitization.
Factors such as the advent of mobile health, wireless solutions, and
telehealth will foster growth opportunities for the digital health
market.
Rising Adoption of mHealth Technologies to Boost Growth
In the coming years, the digital health market is expected to gain
pace in response to the rising adoption of mHealth technologies. These
are advanced technologies that also help in the self-management of
diabetes and other chronic ailments. Taking cue from this, several
companies are launching innovative technologies to help in the same. For
instance, Glooko was launched specifically to help in the management of
diabetes. Similar apps are now increasingly available across
smartphones, making it easier for the healthcare professionals and
patients alike to keep abreast of the most recent patient information.
Development of these technologies is lauded as they are significantly
helping in disease diagnosis and monitoring. These are a few of the
chief digital health market trends that are likely to enable growth in
the coming years. Bolstering this will be the rising penetration of
smartphones, smart devices, and better internet connectivity around the
world.
Demand for Improving Workflow Efficiency to Boost Uptake in Healthcare Organizations
The demand for digital health is rising on account of the increasing
need to improving workflow efficiency across hospitals and other
healthcare organizations. In addition to this, there is mounting
pressure from governments to reduce healthcare costs, while at the same
time focus on improving quality of patient care. Recent advancements in
the technology showcased the inclusion of mobile, big data, cloud, and
interoperability. Following these developments, a surge in the demand
for EHR is observed, subsequently boosting growth prospects for the
digital health market. In addition to this, an increasing number of
companies are investing in developing innovations in EHR. For instance,
Allscripts launched a mobile first and cloud based EHR, dubbed as
Avenel, in 2018. The system uses machine learning to bring down time
taken for clinical documentation. It works more like an application.
Such developments are expected to bode well for the overall market.
Posted by AGORACOM
at 1:54 PM on Wednesday, November 13th, 2019
Sponsor: Loncor is a Canadian gold exploration company focused on two projects in the DRC – the Ngayu and North Kivu projects. Both projects have historic gold production. Exploration at the Ngayu project is currently being undertaken by Loncor’s joint venture partner Barrick Gold. The Ngayu project is 200km southwest of the Kibali gold mine, operated by Barrick, and produced 800,000 ounces of gold in 2018. Barrick manages and funds exploration at the Ngayu project until the completion of a pre-feasibility study on any gold discovery meeting the investment criteria of Barrick. Click Here for More Info
While it is an accepted fact that fundamental events shape the
financial markets, many analysts use technical indicators as a way to
mathematically quantify market sentiment. One of the simplest and most
widely used technical indicators used to determine a current trend for a
stock or commodity are moving averages.
The use of a simple 200-day moving average is used to determine on a
long-term basis whether a financial market is currently in a bullish or
bearish trend. The use of a 50-day moving average is commonly accepted
as determining the short-term trend. In both cases if current pricing is
above the moving average than the trend is bullish.
Another widely accepted technical study is based upon the
mathematician Leonardo Fibonacci’s golden ratio is Fibonacci retracement
theory.
According to Investopedia, “A Fibonacci retracement is a term used in
technical analysis that refers to areas of support or resistance.
Fibonacci retracement levels use horizontal lines to indicate where
possible support and resistance levels are. Each level is associated
with a percentage. The percentage is how much of a prior move the price
has retraced. The Fibonacci retracement levels are 23.6%, 38.2%, 61.8%
and 78.6%. While not officially a Fibonacci ratio, 50% is also used.â€
In this article we will use two Fibonacci retracement studies. The
first study will be a long-term study; however, this study will utilize
much less data then chart number two. The study will begin at the end of
2015 when gold hit a bottom of $1045 per ounce, and concludes at this
year’s current high of $1565 per ounce. The second study will be derived
from another long-term Fibonacci retracement study which begins in
2008, and concludes in the middle of 2011 when gold reached its record
high price against the U.S. dollar.
Of particular interest in the first study are the Fibonacci
retracement areas found at the .23%, and .382% retracement levels.
Currently gold futures are trading at $1457.40, which is a net decline
of $5.50 on the day. This continues the current bearish trend which has
been predominant since gold hit its highest value this year in August.
When you look at the .38% retracement level on this chart you can see
that it precisely defines a level of resistance at approximately $1370.
This was the defined and unbreakable resistance level which began in
2016, the first occurrence of hitting this price point and then trading
lower. This resistance was unbreakable throughout 2017 and 2018. In
fact, it was not until June of this year that gold was able to breach
that price point and trade to its highest value since bottoming out at
the end of 2015.
The other level of particular interest is the .23% Fibonacci
retracement level which occurs at $1446 per ounce. Currently gold
pricing is approximately $11 above that price point. While this study
alone will not confirm a potential bottom or support at $1446, it can
when combined with other technical indicators, be highly effective in
providing price targets for support and resistance.
The second study uses an extremely large data set from 2008 to the
middle of 2011 defining the rally which took gold to its all-time record
high. Of particular interest is the .38% Fibonacci retracement level
which occurs at $1451 per ounce. This defines the lowest price point
gold has traded to this month. It also occurs within dollars of the .23%
Fibonacci retracement level we looked at on chart 1. When you have two
different time sequences which have key Fibonacci retracement levels
occur at the same price point, we label this a Fibonacci harmonic.
While one should never use these technical indicators alone, they are
excellent tools to define price points to look at when a market is in a
corrective stage, which is the current scenario in gold pricing
Posted by AGORACOM
at 9:22 AM on Wednesday, November 13th, 2019
SPONSOR: Gratomic Inc. (TSX-V: GRAT) Advanced
materials company focused on mine to market commercialization of
graphite products, most notably high value graphene based components for
a range of mass market products. Collaborating with Perpetuus, Gratomic
will use Aukam graphite to manufacture graphene products for
commercialization on an industrial scale. For More Info Click Here
Graphene is the lightest, strongest and most electrically conductive substance on Earth
It has many uses in building materials, military equipment and smart technology
The Graphene+ 2019 conference at Swinburne will discuss
cost-effective and sustainable solutions to industry problems using
graphene
Professor Bronwyn Fox will chair a session on the impact of smart factories on jobs and graphene supply chains at the Graphene+ conference held at Swinburne.
Graphene is one of the most innovative materials to be developed and utilised this century.
Researchers at Swinburne have been heavily involved in its
development, innovation and commercialisation. Later this month, the
university will once again host the annual Graphene+ conference,
bringing together industry leaders and academics to discuss the role
graphene will play in the future of manufacturing and infrastructure.
What is graphene?
Graphene is both the lightest and strongest material known to man.
It is a single layer of carbon atoms arranged in a honeycomb-like
structure and is the most electrically conductive substance on Earth.
It was discovered in 2004 by an unusual technique. Researchers from
the University of Manchester in the UK used sticky tape to peel flakes
from a lump of graphite, separating the layers until they were just one
atom thick.
Graphene has proven highly versatile and has been used for building
materials, military equipment, solar cells and smart devices.
Swinburne’s graphene ‘hub’
As part of the Graphene Supply Chain Cooperative Research Centre Projects
(CRC-P), Swinburne is working with industry partner Imagine Intelligent
Materials to develop graphene to meet strict quality assurances and to
be used in large-scale manufacturing. It is also working to establish
industry partnerships.
The material is also a key focus of the Next Generation Materials
program, led by Professor Baohua Jia at Swinburne’s Manufacturing Future
Research Institute (MFRI).
Director of the Manufacturing Future Research Institute, Professor
Bronwyn Fox, says Swinburne researchers are working to establish
standard knowledge and procedures for investors and suppliers of
graphene.
“In the supply chain certification lab, we are developing the
research to understand the relationship between the structure and
performance of graphene so that industry can have security of supply,
ensure successful applications and strengthen future investments in the
technologies that utilise this material.â€
Swinburne researchers have analysed the complete graphene supply
chain – from production to industry practice. They have investigated
graphene’s properties and tested its ability to combine with other
materials in engineering developments, as well its potential to be used
as a thin, protective coating.
Graphene+ 2019
The use of graphene in the development of smart cities will be high on the agenda at the 2019 Graphene+ conference.
Other topics to be discussed include:
Upgrading sensing equipment for the Internet of Things (IoT)
Creating stronger, lightweight architectural structures using the latest in robotics technology
Commercialisation of one-step water purification systems to make drinking water universally available
Enhancing the harnessing and conserving of energy
Jobs of the future – how will graphene change the industry?
Researchers will share knowledge and discuss the potential of
advanced, sustainable and cost-effective technologies, contributing to
the establishment of cities that thrive on smart devices and
infrastructure.
Professor Fox will also chair a session on the impact of smart factories on jobs and graphene supply chains.
“We are fortunate to have some world-leading local and international speakers. The discussions will give us a glimpse of what the future might look like with graphene at the forefront of technology.â€
Posted by AGORACOM-JC
at 3:54 PM on Tuesday, November 12th, 2019
SPONSOR: New Age Metals Inc.
The company’s Lithium Division has already made significant
acquisitions in Canada and the USA. The company also owns one of North
America’s largest primary platinum group metals deposit in Sudbury,
Canada. Updated NI 43-101 Mineral Resource Estimate 2,867,000 PdEq
Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces
in the Inferred. Learn More.
Palladium Prices Soar to Record High
Global Precious Monthly Metals Index (MMI)Â jumped six points this month, rising for a November MMI reading of 113.
As noted here many times before, platinum had historically traded at a premium to palladium.
That relationship, however, flipped as of September 2017, and has remained flipped ever since.
The palladium-platinum spread widened this month, even as platinum made gains.
The spread rose to $850/mt this month, up from $763/mt last month.
Looking Ahead
Gold and silver enjoyed a strong run-up during the summer season, but what is ahead for the precious metals?
“Having risen into the summer, gold and
silver prices have plateaued in Q3 even as some ETFs have seen strong
inflows due to accommodative monetary policies, such as falling Fed
rates and safe haven buying in the face of geopolitical uncertainty,â€
MetalMiner’s Stuart Burns explained. “But jewelry demand is down,
central bank buying of gold is lower than the same time last year and a
strong dollar set up a number of headwinds that have seen prices unwind
as news comes out about a possible winding back of tariffs between the
US and China.â€
As for platinum, prices did not tick up as much as one might have expected given trends in the automotive industry.
“Likewise, platinum prices have failed to
make any headway in Q3 despite a strong showing from other PGMs, such as
palladium and rhodium, both of which continue to benefit from the
switch to petrol internal combustion engines among European carmakers,â€
Burns added.
“Gold, silver and palladium prices are expected to ease further in
the run up to the year-end while other PGMs will be swayed more by car
production and dollar strength. Much will depend on a successful outcome
to the encouraging progress on trade talks, which could see investors
take a more bullish attitude on risk to industrial metals and weaken
demand for safe-haven investment metals.â€
Actual Metal Prices and Trends
The U.S. silver ingot/bar price rose 5.0% month over month to $18.08/ounce as of Nov. 1.
U.S. platinum bars rose 6.3% to $930/ounce. U.S. palladium bars jumped 8.7% to $1,780/ounce.
Chinese gold bullion rose 1.7% to $48.79/gram. U.S. gold bullion increased 2.3% to $1,512.70/ounce.
Posted by AGORACOM-JC
at 2:10 PM on Tuesday, November 12th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
EKG: TSX-V ———————-
Visualising Mhealth in 2019
In the age of digital transformation, more and more professions are making use of new technologies, and the world of health care is no exception.
In fact, mobile devices are becoming an increasingly important part of modern healthcare delivery.
It has been found that mobile devices can help to streamline and improve many healthcare functions.
Mobile devices have now become an essential tool for healthcare and medical workers, with four-fifths of workers using mobiles as part of their everyday work.
mHealth: transforming healthcare in the 21st century
The World Health Organisation (WHO) defines mHealth as “medical and
public health practice supported by mobile devices, such as mobile
phones, patient monitoring devices, personal digital assistances and
other wireless devicesâ€. Over the past decade, this sector has enjoyed
tremendous growth and it is now projected to hit a global value of $60
billion by 2020.
What are the benefits of mHealth technology for professionals?
Mobile devices allow medical professionals to easily access patients’
electronic health records and data. This has a positive effect on
productivity as information can be rapidly accessed and it is far less
likely to be lost or mishandled.
Mobile technologies offer a useful communication tool for medical
professionals. For example, professionals can use note-taking and
communication apps to easily exchange information between relevant
parties. This ensures a greater quality of care for the patient by
boosting information management and by encouraging collaboration.
Many mHealth apps are designed with the aim of facilitating better
communication between patients and their healthcare providers. Patients
can use apps to track symptoms and medication usage, and this will go a
long way to improve communication with healthcare workers.
Discover more about mHealth
The below infographic from Home Healthcare Adaptations
visually demonstrates how medical and healthcare professionals are
using mobile devices in their work. The guide features statistics about
mHealth and also includes an easy-to-understand summary of the key
benefits and challenges associated with the use of mobile devices in
health care.
Posted by AGORACOM-JC
at 10:38 AM on Tuesday, November 12th, 2019
SPONSOR: NORTHBUD (NBUD:CSE)
Sustainable low cost, high quality cannabinoid production and
procurement focusing on both bio-pharmaceutical development and
Cannabinoid Infused Products. Learn More.
NBUD: CSE —————————–
5 Reasons Why Everyone Is Obsessed With CBD Gummies
If you’ve heard any of the hype lately about CBD and CBD gummies, you’re probably thinking, “what’s all the fuss about?†With
last year’s introduction of the Farm Bill, the CBD industry has
skyrocketed beyond anyone’s expectations, creating countless products
infused with the cannabinoid CBD. With numerous health
benefits, availability and affordability, CBD products are making quite
the scene in a new(er) industry. Here are five reasons why everyone is
obsessed with CBD gummies.
Availability
CBD gummies are pretty much everywhere at this point. You
can get them online, in your drug store, in holistic health shops, and
more. With such wide availability, it’s no wonder these tasty treats are
a favorite among consumers of CBD. That being said, it’s important to
note that not all CBD gummies are the same.
The quality of the CBD used in them can have a profound effect on the
effectiveness, so it’s always better to purchase from a provider with a
good reputation for quality. Companies like Verma Farms offer some of the highest-quality CBD gummies on the market.
Be sure to check the CBD availability and legality in your state.
While hemp may be legal on the federal level, individual states still
have the ability to regulate and even ban hemp and CBD products.
Longer-Lasting Effects
Img source: kushiebites.com
Since CBD gummies are ingested, the effects of the CBD tend to last
longer than if it were inhaled or taken under the tongue. The slow
process of digestion means that your CBD might take an hour or longer to
kick in, but once it does, you can expect the effect to last for at
least a few hours.
The longer-lasting effects of the gummies are mostly what drives
consumers to make these a favorite. They also taste pretty good too!
Straight CBD oil taken under the tongue can leave a plant aftertaste,
which can be quite unpleasant. Chewing a gummy eliminates this
unpleasantness by coating the CBD with a tasty, sugary gummy.
Consumers feel like gummies give them a bit more bang for their buck
since some CBD products can be quite pricey. With longer-lasting
effects, you’ll need less throughout the day to achieve the desired
effect; making them an affordable and effective way to enjoy CBD.
CBD’s Benefits
Let’s take a moment to talk about some of the great effects that CBD has on the body. From reducing stress and anxiety
to improved sleep, the effects of CBD are numerous and positive. While
the research is still pretty much in its infancy, what we do know is that CBD so far hasn’t shown any major negative side-effects.
CBD is different from THC, though they’re both found in the cannabis
plant. THC creates the euphoric “high†that marijuana is known for,
whereas CBD is much the opposite. Instead of euphoria, users have said
that they feel clarity and calm. It’s even been said that CBD can help
reduce the effects of THC for when you’ve had a little too much
People all over the world are using CBD oils and gummies for joint
aches, concentration, treating anxiety, and all manner of health
ailments. Some users swear by CBD as a cure-all, but science has yet to discover the true spectrum of benefits offered by this amazing compound.
Affordability
Img source: kushiebites.com
While CBD oils and vape pens can be a bit costly, CBD gummies remain
on the affordable end of the spectrum, and, as stated above, their
long-lasting effects makes them much more cost-efficient than their
inhaled or absorbed counterparts. We’ve seen hundreds of brands pop up
over the course of the last year, and as the industry grows, we’re
certain to see more. Right now, CBD demand is high, so prices will probably remain at about the same level for the coming years.
Easy to Take
Probably the best thing about CBD gummies
is that they’re easy to take. Whether you’re 21 or 71, chewing them is
simple and the digestive process does all of the work for you. Where
vape pens and oils can require different processes for maximum
effectiveness, with this product, you simply chew and swallow and wait.
This makes gummies accessible to people of all ages, backgrounds, and
ailments. The availability and versatility of these awesome products
are what have made them an absolute favorite among CBD users nationwide.
Conclusion
Img source: whio.com
Whether you’re new to CBD or a seasoned veteran, you’ll want to give
CBD gummies a try to see why everyone’s raving about them. From being
easy to take to having longer-lasting effects, they can offer a unique
CBD product that you’ll find is both simple and affordable.
